Plant-Based Vaccines Market Anticipated To Witness Robust Growth, Surpassing $2.79 Billion By 2029

The Plant-Based Vaccines Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Plant-Based Vaccines Market Size and Its Estimated Growth Rate?
The size of the market for plant-based vaccines has seen fast-paced growth in recent years. The market, which was worth $1.66 billion in 2024, is projected to increase to $1.83 billion in 2025, representing a compound annual growth rate (CAGR) of 10.2%. The expansion observed during the historical period is primarily due to difficulties encountered in traditional vaccine production, the need for a more financially viable vaccine production process, the rise of plant molecular farming, decreased potential for allergies, and the application of synthetic biology.

Expectations are high for the plant-based vaccines market to expand swiftly in the upcoming years, reaching a worth of $2.79 billion in 2029, a feat made possible by a compound annual growth rate (CAGR) of 11.1%. Factors like readiness for pandemics, worldwide health security, broadening of vaccine uses and embrace by the pharmaceutical industry significantly contribute to the anticipated growth within this forecast period. Key trends to watch within this timeframe encompass progress in plant biotechnology, the pursuit of environmental sustainability, the incorporation of artificial intelligence as well as machine learning.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12144

How Are Emerging Segments Shaping the Plant-Based Vaccines Market Landscape?
The plant-based vaccines market covered in this report is segmented -

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types
2) By Source: Tobacco Plant, Maize, Potato, Other Sources
3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:
1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines
2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines
3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines
4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

Which Growth Factors Are Influencing Plant-Based Vaccines Market Expansion?
The surge in infectious diseases is anticipated to drive the expansion of the plant-based vaccine market. Infectious diseases are illnesses caused by microorganisms such as bacteria, parasites, viruses, and fungi. Employed in both traditional and contemporary medicine, plant-based vaccines are instrumental in the development of safe, effective, stable, and affordable vaccines, preventative treatments, and medicines, particularly for infectious diseases. For example, the Global Tuberculosis Report from the World Health Organization, a Switzerland-based global health organization, stated in October 2022 that the global tuberculosis (TB) incidence was estimated to be 10.6 million cases, with a rate of 134 cases per 100,000 people. The Southeast Asia region reported most TB cases with 45% of the total cases, followed by Africa with 23%. Therefore, the widespread presence of infectious diseases is fueling the growth of the plant-based vaccine market.

Who Are the Dominant Players Across Different Plant-Based Vaccines Market Segments?
Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

What Are the Latest Developing Trends in the Plant-Based Vaccines Market?
Emerging as a major trend in the plant-based vaccine market is product innovation. Key players in the market are channeling their resources toward developing unique products to maintain their market dominance. For example, in February 2022, Canadian biopharmaceutical firm Medicago Inc., in collaboration with UK-based pharma and biotech company GSK PLC, announced that their COVID-19 vaccine, COVIFENZ, had been given the green light by Health Canada. A first of its kind, COVIFENZ is a plant-based, virus-like particles [VLP], recombinant, adjuvanted vaccine for COVID-19. The vaccine, which employs COVID-19-like particle (CoVLP) technology, is constructed from recombinant spike (S) glycoproteins created as virus-like particles (VLPs).

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

Which Geographic Regions Are Expected to Dominate the Plant-Based Vaccines Market in the Coming Years?
North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Plant-Based Vaccines Market?
2. What is the CAGR expected in the Plant-Based Vaccines Market?
3. What Are the Key Innovations Transforming the Plant-Based Vaccines Industry?
4. Which Region Is Leading the Plant-Based Vaccines Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.